Blue Chip๐Ÿ“ˆ ASX

ResMed Inc. (ASX: RMD)

Published 28 April 2026Healthcare Pulse Report
ResMed Inc. ASX: RMD ResMed, Inc. is a digital health and cloud-based medical devices provider for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed has Sleep and Respiratory Care and SaaS segments, and also provides software to out-of-hospital providers. It was established in 1989 by Peter Farrell and is based in San Diego, Califo
๐Ÿ”’

Subscribers only

Sign in with your subscriber account or subscribe to access this research report.

Required subscription
Healthcare Pulse Report
A$1200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Healthcare Pulse Report
Stay informed on Australia's healthcare sector with expert research covering healthcare, biotechnology, medical technology, and life sciences companies listed on the ASX.
  • โœ“ ASX Healthcare & Biotech Research
  • โœ“ Delivered Fortnightly every 2nd & 4th Tuesday
  • โœ“ Industry Trends & Risk Analysis
  • โœ“ Full Historical Report Access
A$1200.00/ 12 months
Risk:High
Subscribe Now โ†’